Last update 23 Jan 2025

SHR-2010

Overview

Basic Info

Drug Type
Antibody
Synonyms
Target
MASP2
Mechanism
MASP2 inhibitors(Mannan-binding lectin serine protease 2 inhibitors)
Therapeutic Areas
Immune System DiseasesUrogenital Diseases
Active Indication
Glomerulonephritis, IGA
Inactive Indication-
Originator Organization
Guangdong Hengrui Pharmaceutical Co., Ltd.
Active Organization
Guangdong Hengrui Pharmaceutical Co., Ltd.Suzhou Suncadia Biopharmaceuticals Co., Ltd.Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with SHR-2010
CTR20231326
/ RecruitingPhase 2
一项II期无缝设计、随机、双盲、安慰剂对照、剂量探索研究评估SHR-2010注射液治疗原发性IgA肾病患者的疗效和安全性
[Translation] A Phase II seamless design, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the efficacy and safety of SHR-2010 injection in patients with primary IgA nephropathy
NCT05847920
/ RecruitingPhase 2
A Phase II Seamless Design, Randomized, Double-blind, Placebo-controlled, Dose-exploration Study Evaluate the Efficacy and Safety of SHR-2010 Injection in Patients With Primary IgA Nephropathy
CTR20221324
/ CompletedPhase 1
单次静脉/皮下注射SHR-2010在健康受试者的安全性、耐受性及药代动力学、药效学研究——随机、双盲、剂量递增、安慰剂对照I期临床试验
[Translation] Safety, tolerability, pharmacokinetics and pharmacodynamics of a single intravenous/subcutaneous injection of SHR-2010 in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I clinical trial
100 Clinical Results associated with SHR-2010
Login to view more data
100 Translational Medicine associated with SHR-2010
Login to view more data
100 Patents (Medical) associated with SHR-2010
Login to view more data
100 Deals associated with SHR-2010
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glomerulonephritis, IGAPhase 2
CN
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Suzhou Suncadia Biopharmaceuticals Co., Ltd.
04 Jun 2023
Glomerulonephritis, IGAPhase 2
CN
Guangdong Hengrui Pharmaceutical Co., Ltd.
04 Jun 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free